Scientific, peer-reviewed, clinical
publications about Tris Pharma products

Publications

Click on any title below to read the full article or abstract.

Amphetamine Extended-Release Tablet

Amphetamine Extended-Release Oral Suspension

Single-dose pharmacokinetics of amphetamine extended-release oral suspension in healthy adults. Herman BK, Bouhajib M, King TR, Kando JC, Pardo A. J Atten Disord. 2021;25(6):803-808. doi: 10.1177/1087054719841131.
Efficacy and safety of amphetamine extended-release oral suspension in children with attention-deficit/hyperactivity disorder. Childress AC, Wigal SB, Brams MN, et al. J Child Adolesc Psychopharmacol. 2018;28(5):306-313.

Methylphenidate Extended-Release Tablet

Methylphenidate Extended-Release Oral Suspension

Efficacy, safety, and tolerability of a novel methylphenidate extended-release oral suspension (MEROS) in ADHD. Robb AS, Findling RL, Childress AC, Berry SA, Belden HW, Wigal SB. J Atten Disord. 2017;21(14):1180-1191.
Effect of food intake on the pharmacokinetics of a novel methylphenidate extended-release oral suspension for attention deficit hyperactivity disorder. Sallee FR, Palumbo DR, Abbas R, Berry SA, Puthili SP, Kathala KK. Clin Pharmacol Drug Dev. 2017;6(5):476-483.